Occult hepatitis B infection in Portuguese patients with chronic hepatitis C liver disease: Prevalence and clinical significance

European Journal of Gastroenterology and Hepatology

Volumn 25, Issue 2, 2013, Pages 142-146

  Cardoso, Claudia ^a   Alves, Ana L ^a   Augusto, Fátima ^a   Freire, Ricardo ^a   Quintana, Carlos ^a   Gonçalves, Matilde ^a   Oliveira, Ana P ^a  

^a São Bernardo Hospital   (Portugal)

Author keywords

Chronic hepatitis C; Nested PCR; Occult hepatitis B infection

Indexed keywords

ALANINE AMINOTRANSFERASE; HEPATITIS B ANTIBODY; HEPATITIS B CORE ANTIBODY; PEGINTERFERON; RIBAVIRIN; VIRUS DNA; VIRUS RNA;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIBODY BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; DISEASE SEVERITY; FEMALE; GENOTYPE; HEPATITIS B; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN TISSUE; LIVER BIOPSY; LIVER HISTOLOGY; MAJOR CLINICAL STUDY; MALE; OCCULT HEPATITIS B; OUTPATIENT; POLYMERASE CHAIN REACTION; PORTUGAL; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROLOGY; STEATOSIS; TREATMENT RESPONSE; VIRUS LOAD;

ADULT; ANTIVIRAL AGENTS; BIOLOGICAL MARKERS; CARRIER STATE; COINFECTION; DNA, VIRAL; DRUG THERAPY, COMBINATION; FEMALE; HEPACIVIRUS; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C, CHRONIC; HUMANS; INTERFERONS; LIVER; MALE; MIDDLE AGED; PORTUGAL; PROSPECTIVE STUDIES; RIBAVIRIN; VIRAL LOAD;

EID: 84872065677     PISSN: 0954691X     EISSN: 14735687     Source Type: Journal    
DOI: 10.1097/MEG.0b013e328359fe54     Document Type: Article

References (34)

1. Bre'chot C, Degos F, Lugassy C, Thiers V, Zafrani S, Franco D, et al. Hepatitis B virus DNA in patients with chronic liver disease and negative tests for hepatitis B surface antigen. N Engl J Med 1985; 312:270-276 (Pubitemid 15199365)
2. Pontisso P, Ruvoletto MG, Fattovich G, Chemello L, Gallorini A, Ruol A, et al. Clinical and virological profiles in patients with multiple hepatitis virus infections. Gastroenterology 1993; 105:1529-1533 (Pubitemid 23315331)
3. Koike K, Kobayashi M, Gondo M, Hayashi I, Osuga T, Takada S. Hepatitis B virus DNA is frequently found in liver biopsy samples from hepatitis C virus infected chronic hepatitis patients. J Med Virol 1998; 54:249-255 (Pubitemid 28185416)
4. Lee DS, Huh K, Lee EH, Hong KS, Sung YC. HCV and HBV coexist in HBsAg-Negative patients with HCV viraemia: Possibility of coinfection in these patients must be considered in HBV-high endemic area. J Gastroenterol Hepatol 1997; 12:855-861 (Pubitemid 28088072)
5. Fukuda R, Ishimura N, Niigaki M, Hamamoto S, Satoh S, Tanaka S, et al. Serologically silent hepatitis B virus coinfection in patients with hepatitis C virus associated chronic liver disease: Clinical and virological significance. J Med Virol 1999; 58:201-207 (Pubitemid 29278020)
6. Fabris P, Brown D, Tositti G, Bozzola L, Giordani MT, Bevilcqua P, et al. Occult hepatitis B virus infection does not affect liver histology or response to therapy with interferon alpha and ribavirin in intravenous drug users with chronic hepatitis C. J Clin Virol 2004; 29:160-166 (Pubitemid 38201461)
7. Georgiadou SP, Zachou K, Rigopoulou E, Liaskos C, Mina P, Gerovasilis F, et al. Occult hepatitis B virus infection in Greek patients with chronic hepatitis C and in patients with diverse nonviral hepatic diseases. J Viral Hepat 2004; 11:358-365 (Pubitemid 38961881)
8. Hasegawa I, Orito E, Tanaka Y, Hirashima N, Sakakibara K, Sakurai M, et al. Impact of occult hepatitis B virus infection on efficacy and prognosis of interferon-Alpha therapy for patients with chronic hepatitis C. Liver Int 2005; 25:247-253
9. Silva C, Goncales NS, Pereira JS, Escanhoela CA, Pavan MH, Goncales FL Jr. The influence of occult infection with hepatitis B virus on liver histology and response to interferon treatment in chronic hepatitis C patients. Braz J Infect Dis 2004; 8:431-439
10. Mrani S, Chemin I, Menouar K, Guillaud O, Pradat P, Borghi G, et al. Occult HBV infection may represent a major risk factor of non-response to antiviral therapy of chronic hepatitis C. J Med Virol 2007; 79:1075-1081 (Pubitemid 47015405)
11. Miura Y, Shibuya A, Adachi S, Takeuchi A, Tsuchihashi T, Nakazawa T, et al. Occult hepatitis B virus infection as a risk factor for hepatocellular carcinoma in patients with chronic hepatitis C in whom viral eradication fails. Hepatol Res 2008; 38:546-556 (Pubitemid 351622280)
12. Zarski JP, Bohn B, Bastie A, Pawlotsky JM, Baud M, Bost-Bezeaux F, et al. Characteristics of patients with dual infection by hepatitis B and C viruses. J Hepatol 1998; 28:27-33 (Pubitemid 28122496)
13. Hollinger FB, Sood G. Occult hepatitis B virus infection: A covert operation. J Viral Hepat 2010; 17:1-15
14. Laras A, Koskinas J, Dimou E, Kostamena A, Hadziyannis SJ. Intrahepatic levels and replicative activity of covalently closed circular hepatitis B virus DNA in chronically infected patients. Hepatology 2006; 44:694-702 (Pubitemid 44433726)
15. Werle- Lapostolle B, Bowden S, Locarnini S. Persistence of cccDNA during the natural history of chronic hepatitis B and decline during adefovir dipivoxil therapy. Gastroenterology 2004; 126:1750-1758 (Pubitemid 38736340)
16. Nowak MA, Bonhoeffer S, Hill AM, Boehme R, Thomas HC, McDade H. Viral dynamics in hepatitis B virus infection. Proc Natl Acad Sci USA 1996; 93:4398-4402 (Pubitemid 26144299)
17. Ganem D. Assembly of hepadnaviral virions and subviral particles. Curr Top Microbial Immunol 1991; 168:61-83
18. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Villari D, de Franchis R, et al. Quantification of intrahepatic hepatitis B virus (HBV) DNA in patients with chronic HBV infection. Hepatology 2000; 31:507-512 (Pubitemid 30078620)
19. Pollicino T, Raffa G, Costantino L, Lisa A, Campello C, Squadrito G, et al. Molecular and functional analysis of occult hepatits B virus isolates from patients with hepatocellular carcinoma. Hepatology 2007; 45:277-285 (Pubitemid 46374584)
20. Pontisso P, Gerotto M, Benvegnu L, Chemello L, Alberti A. Coinfection by hepatitis B virus and hepatitis C virus. Antivir Ther 1998; 3:137-142 (Pubitemid 28528329)
21. Raimondo G, Navarra G, Mondello S, Costantino L, Colloredo G, Cucinotta E, et al. Occult hepatitis B virus in liver tissue of individuals without hepatic disease. J Hepatol 2008; 48:743-746
22. Penna A, Artini M, Cavalli A, Levrero M, Bertoletti A, Pilli M, et al. Longlasting memory T cell responses following self-Limited acute hepatitis B. J Clin Invest 1996; 98:1185-1194 (Pubitemid 26299932)
23. Guidotti LG, Rochford R, Chung J, Shapiro M, Purcell R, Chisari FV. Viral clearance without destruction of infected cells during acute HBV infection. Science 1999; 284:825-829 (Pubitemid 29291352)
24. Rehermann B, Ferrari C, Pasquinelli C, Chisari FV. The hepatitis B virus persists for decades after patients' recovery from acute viral hepatitis despite active maintenance of a cytotoxic T-Lymphocyte response. Nat Med 1996; 2:1104-1108 (Pubitemid 26338629)
25. Blum HE, Galun E, Liang TJ, von Weizsäcker F, Wands Jr. Naturally occurring missense mutation in the polymerase gene terminating hepatitis B virus replication. J Virol 1991; 65:1836-1842
26. Jeantet D, Chemin I, Mandrand B, Tran A, Zoulim F, Merle P, et al. Cloning and expression of surface antigens from occult chronic hepatitis B virus infections and their recognition by commercial detection assays. J Med Virol 2004; 73:508-515 (Pubitemid 38857199)
27. Hu KQ. Occult hepatitis B virus infection and its clinical implications. J Viral Hepat 2002; 9:243-257
28. Ohkawa K, Hayashi N, Yuki N, Masuzawa M, Kato M, Yamamoto K, et al. Long term follow up of hepatitis B virus and hepatitis C virus replicative levels in chronic hepatitis patients coinfected with both viruses. J Med Virol 1995; 46:258-264
29. Sheen IS, Liaw YF, Chu CM, Pao CC. Role of hepatitis C virus infection in spontaneous hepatitis B surface antigen clearance during hepatitis B virus infection. J Infect Dis 1992; 165:831-834
30. Squadrito G, Orlando ME, Pollicino T, Raffa G, Restuccia T, Cacciola I, et al. Virological profiles in patients with chronic hepatitis C and overt or occult HBV infection. Am J Gastroenterol 2002; 97:1518-1523 (Pubitemid 34664803)
31. Jardi R, Rodriguez F, Buti M, Costa X, Cotrina M, Galimany R, et al. Role of hepatitis B, C and D viruses in dual and triple infection: Influence of viral genotypes and hepatitis B precore and basal core promoter mutations on viral replicative interference. Hepatology 2001; 34:404-410 (Pubitemid 32702354)
32. Schüttler CG, Fiedler N, Schmidt K, Repp R, Gerlich WH, Schaefer S. Suppression of hepatitis B virus enhancer 1 and 2 by hepatitis C virus core protein. J Hepatol 2002; 37:855-862 (Pubitemid 35404227)
33. Cacciola I, Pollicino T, Squadrito G, Cerenzia G, Orlando ME, Raimondo G. Occult hepatitis B virus infection in patients with chronic hepatitis c liver disease. N Engl J Med 1999; 341:22-26 (Pubitemid 29293716)
34. Carrěo V, Bartolomé J, Castillo I, Quiroga JA. Occult hepatitis B virus and hepatitis C virus infections. Rev Med Virol 2008; 18:139-157 (Pubitemid 351693493)